Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
The addition of nanomolar concentration of TRAF2 in GUVs also seems to exert a mechanical action.
TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 (show CRTC2 ELISA Kits) signalling
destabilization of TRAF2 by miR-17 reduced the ability of TRAF2 to associate with cIAP2 (show BIRC3 ELISA Kits), resulting in the downregulation of TNF-alpha (show TNF ELISA Kits)-induced NF-kappaBp65, c-Jun (show JUN ELISA Kits), and STAT3 (show STAT3 ELISA Kits) nuclear translocation and the production of IL-6 (show IL6 ELISA Kits), IL-8 (show IL8 ELISA Kits), MMP-1 (show MMP1 ELISA Kits), and MMP-13 (show MMP13 ELISA Kits) in human rheumatoid arthritis synovial fibroblasts.
HOXA1 (show HOXA1 ELISA Kits)-mediated activation of NF-kappaB (show NFKB1 ELISA Kits) is non-transcriptional and the RBCK1 (show RBCK1 ELISA Kits) and TRAF2 influences on NF-kappaB (show NFKB1 ELISA Kits) are epistatic to HOXA1 (show HOXA1 ELISA Kits)
RIPK1 (show RIPK1 ELISA Kits) collaborates with TRAF2 to inhibit murine and human hepatocarcinogenesis.
Data suggest that TRAF2 (TNF receptor-associated factor 2) negatively regulates (1) TNFR1- (tumor necrosis factor binding protein 1 (show TNFRSF1A ELISA Kits))-induced apoptosis, (2) TNFR2 (show TNFRSF1B ELISA Kits)- (tumor necrosis factor (show TNF ELISA Kits) receptor type 2)-induced non-canonical NFkappaB (show NFKB1 ELISA Kits) signaling, and (3) TNF- (tumor necrosis factor (show TNF ELISA Kits))-induced necroptosis. [REVIEW]
Study presents the characterization of the peptide binding preferences of TRAFs 2, 3, and 5 using deep mutational scanning. The three TRAF (show TRAF1 ELISA Kits) proteins demonstrated different preferences for binding to members of the CD40 (show CD40 ELISA Kits) library, and three peptides from that library individually showed striking differences in affinity for the three TRAFs.
The data demonstrate a novel and unexpected function of BIG1 (show CNTN3 ELISA Kits) that regulates TNFR1 (show TNFRSF1A ELISA Kits) signaling by targeting TRAF2.
TRAF2 expression was increased in gastric cancer patients as a result of DNA hypomethylation.
Data show that when death receptor 5 (DR5 (show TNFRSF10B ELISA Kits)) is suppressed, caspase-8 (show CASP8 ELISA Kits) may recruit and stabilize TNF receptor-associated factor 2 (TRAF2) to form a metastasis and invasion signaling complex, resulting in activation of ERK (show EPHB2 ELISA Kits) signaling.
work reveals that simulated microgravity promotes the apoptotic response through a combined modulation of the Uev1A/TICAM/TRAF (show TRAF1 ELISA Kits)/NF-kappaB (show NFKB1 ELISA Kits)-regulated apoptosis and the p53 (show TP53 ELISA Kits)/PCNA (show PCNA ELISA Kits)- and ATM (show ATM ELISA Kits)/ATR (show ATR ELISA Kits)-Chk1 (show CHEK1 ELISA Kits)/2-controlled DNA-damage response pathways.
Traf2 mediates the pro-survival pathway in the heart by suppressing necroptotic signaling.
Targeting TRAF2 may be useful as a therapeutic approach for immunosuppression-free islet allograft survival that avoids the thromboembolic complications associated with the use of anti-CD40L (show CD40LG ELISA Kits) antibodies.
Celastrol promotes Nur77 (show NR4A1 ELISA Kits) migration from the nucleus to mitochondria, where it is ubiquitinated by TRAF2. Ubiquitinated Nur77 (show NR4A1 ELISA Kits) then interacts with p62/SQSTM1 (show SQSTM1 ELISA Kits), leading to autophagy of dysfunctional mitochondria and alleviation of inflammation.
this study shows that TRAF2 and TRAF5 (show TRAF5 ELISA Kits) work as important regulators of the IL-6R signaling needed for Th17 development
Keratinocyte-specific deletion of Traf2, but not Sphk1 (show SPHK1 ELISA Kits) deficiency, disrupted TNF (show TNF ELISA Kits) mediated NF-kappaB (show NFKB1 ELISA Kits) and MAP kinase (show MAPK1 ELISA Kits) signalling and caused epidermal hyperplasia and psoriatic skin inflammation.
TRAF2 functions as a key activator of MST1 (show MST1 ELISA Kits) in oxidative stress-induced (show SQSTM1 ELISA Kits) intracellular signaling processes.
Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages.
NFkappaB anti-apoptotic target genes TNF receptor-associated factor 1 (TRAF1 (show TRAF1 ELISA Kits)), TNF receptor-associated factor 2 (TRAF2), cellular inhibitor of apoptosis (cIAP2 (show BIRC3 ELISA Kits)), and Ferritin heavy chain (FTH1 (show FTH1 ELISA Kits)) were increased following Losartan treatment
The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined.
, conjugal transfer protein TraF
, E3 ubiquitin-protein ligase TRAF2
, tumor necrosis factor type 2 receptor associated protein 3
, tumor necrosis factor type 2 receptor-associated protein 3
, TRAF family member-associated NFKB activator
, TNF receptor-associated factor 2